Financials

  • Market Capitalization 11.35 M
  • Employee 8
  • Founded 2011
  • CEO Paul Kang
  • Website www.exicuretx.com
  • Headquarter Delaware, United States
  • FIGI BBG00GTJCSB4
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-6.86
ratio cours/chiffre d'affaires

Related tickers

#NomPrix24h %7 jours %1M %1 an %Cap Boursière7 Derniers Jours
4796
KPRX
Kiora Pharmaceuticals, Inc. - Common Stock
2.51 USD+2.03%-1.95%-1.57%+19.52%11.12 M USD
4802
TRAW
Traws Pharma, Inc. - Common Stock
0.71 USD+4.41%-2.74%-34.86%-54.19%10.76 M USD
4806
TOVX
Theriva Biologics, Inc. Common Stock
0.25 USD+8.70%+8.70%-13.79%+0.97%11.47 M USD
4811
VTGN
Vistagen Therapeutics, Inc. - Common Stock
0.24 USD-4.00%0.00%-59.32%-53.41%9.85 M USD

Nouvelles